Product image of Brivaracetam Cinfa (Brivaracetam) supplied by GNH India

Brivaracetam Cinfa

Active Ingredient:
Brivaracetam
Origin:
EU

Brivaracetam Cinfa (Brivaracetam)

Brivaracetam Cinfa is an antiepileptic medication used to manage seizures. This oral medication is manufactured by Laboratorios Cinfa S.A. in the EU, offering a reliable option for seizure control.

Manufacturer / TM Owner

Laboratorios Cinfa S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Brivaracetam Cinfa is primarily used to treat epilepsy by helping to control seizures. It works by affecting certain chemicals in the brain that may be involved in causing seizures. This medication is often prescribed for patients who have not responded well to other seizure medications.

Side Effects

  • Common effects of Brivaracetam Cinfa may include dizziness, fatigue, and nausea. Some users may also experience headaches or somnolence. These effects vary from person to person and are generally mild to moderate in nature.

Precautions & Warnings

  • Brivaracetam Cinfa should be handled with care, especially by individuals with a history of liver or kidney problems. It is important to follow the advice of a healthcare professional regarding its use. Always store the medication in a cool, dry place away from direct sunlight.

Avoid Interactions

  • Brivaracetam Cinfa may interact with other medications, including those metabolized by the liver. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect how this medication works.

Frequently Asked Questions

Brivaracetam Cinfa is used to manage seizures in patients with epilepsy. It helps control seizures by affecting certain chemicals in the brain.

Brivaracetam Cinfa is taken orally, typically as directed by a healthcare professional. It is important to follow the prescribed dosage and administration instructions.

Common side effects may include dizziness, fatigue, nausea, headaches, and somnolence. These effects vary in severity and frequency among users.

Brivaracetam Cinfa may interact with other medications, especially those metabolized by the liver. Always consult a healthcare provider before combining it with other treatments.

The safety of Brivaracetam Cinfa for long-term use should be discussed with a healthcare professional. Regular monitoring and follow-up are recommended.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Brivaracetam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT